|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||5.74 - 6.10|
|52-week range||5.08 - 15.47|
|Beta (5Y monthly)||1.72|
|PE ratio (TTM)||N/A|
|Earnings date||08 Aug 2022 - 12 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||13.78|
LONDON, April 29, 2022--Curaleaf International (the "Company") part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce the successful license of the Company’s range of cannabis based medicines as extract, under the name Adven, in Malta.
U.S. Cannabis Council President & CEO Steve Hawkins joins Yahoo Finance Live to talk about cannabis legalization and sales in New Jersey, promises on marijuana regulation made by politicians, and the pathway towards federal legalization.
The cannabis industry has been disappointed with Democratic political leadership in the fight for national marijuana legislation, executives say.